Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Operations (Unaudited)

v3.20.2
Condensed Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Income Statement [Abstract]        
Revenue
Cost of revenue 153,500 307,000
Gross loss (153,500) (307,000)
Operating expenses:        
Research and development 423,174 750,395 1,795,696 1,070,766
Selling, general and administrative 1,659,612 1,492,483 9,597,169 2,868,391
Total operating expenses 2,082,786 2,242,878 11,392,865 3,939,157
Loss from operations (2,082,786) (2,396,378) (11,392,865) (4,246,157)
Other income (expense):        
Other income (expense) (54,226) (54,226)
Interest expense (1,089,804) (393,320) (2,324,017) (916,599)
Loss on exchange of notes payable for common stock and warrants (1,498,901) (1,521,348)
Loss on extinguishment of debt (179,400) (197,600)
Change in fair value of warrant liability (861,365) (11,482) (738,456) 136,326
Total other expense (3,683,696) (404,802) (4,835,647) (780,273)
Net loss $ (5,766,482) $ (2,801,180) $ (16,228,512) $ (5,026,430)
Net loss per share, basic and diluted: $ (0.22) $ (0.24) $ (0.75) $ (0.46)
Weighted average shares outstanding, basic and diluted: 25,645,519 11,625,368 21,532,383 11,314,802